Mitochondrial involvement in non-alcoholic steatohepatitis

Molecular Aspects of Medicine

Volumn 29, Issue 1-2, 2008, Pages 22-35

  Serviddio, Gaetano ^a,b   Sastre, Juan ^b   Bellanti, Francesco ^a   Viña, José ^b   Vendemiale, Gianluigi ^a,c   Altomare, Emanuele ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF VALENCIA   (Spain)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

ATP homeostasis; Fatty liver; HNE; Mitochondria; NASH; Reactive oxygen species; UCP2

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; ALPHA TOCOPHEROL; ASCORBIC ACID; BIGUANIDE DERIVATIVE; CARDIOLIPIN; FIBRIC ACID DERIVATIVE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; MELATONIN; METFORMIN; REACTIVE OXYGEN METABOLITE; SILIBININ; TROLOX C; UNCOUPLING PROTEIN 2; URSODEOXYCHOLIC ACID;

CELL DEATH; CYTOKINE RELEASE; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG INHIBITION; DRUG PROTEIN BINDING; ENERGY METABOLISM; FATTY ACID OXIDATION; GLUTATHIONE METABOLISM; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; LIPID PEROXIDATION; LIVER CELL; METABOLIC SYNDROME X; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PATHOGENESIS; REVIEW;

ADENOSINE TRIPHOSPHATE; ANIMALS; FATTY LIVER; HUMANS; LIPID METABOLISM; MITOCHONDRIA; MODELS, BIOLOGICAL; REACTIVE OXYGEN SPECIES;

EID: 39749127250     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2007.09.014     Document Type: Review

References (112)

1. Angulo P. Nonalcoholic fatty liver disease. New Engl. J. Med. 346 (2002) 1221-1231
2. Baffy G., Zhang C.Y., Glickman J.N., and Lowell B.B. Obesity-related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2. Hepatology 35 (2002) 753-761
3. Bartlett K., and Eaton S. Mitochondrial beta-oxidation. Eur. J. Biochem. 271 (2004) 462-469
4. Begriche K., Igoudjil A., Pessayre D., and Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6 (2006) 1-28
5. Boss O., Muzzin P., and Giacobino J.P. The uncoupling proteins, a review. Eur. J. Endocrinol. 139 (1998) 1-9
6. Boveris A., Oshino N., and Chance B. The cellular production of hydrogen peroxide. Biochem. J. 128 (1972) 617-630
7. Brady L.J., Brady P.S., Romsos D.R., and Hoppel C.L. Elevated hepatic mitochondrial and peroxisomal oxidative capacities in fed and starved adult obese (ob/ob) mice. Biochem. J. 231 (1985) 439-444
8. Brandt J.M., Djouadi F., and Kelly D.P. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha. J. Biol. Chem. 273 (1998) 23786-23792
9. Brinkman K., ter Hofstede H.J., Burger D.M., Smeitink J.A., and Koopmans P.P. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 12 (1998) 1735-1744
10. Cai Y., Nelson B.D., Li R., Luciakova K., and dePierre J.W. Thyromimetic action of the peroxisome proliferators clofibrate, perfluorooctanoic acid, and acetylsalicylic acid includes changes in mRNA levels for certain genes involved in mitochondrial biogenesis. Arch. Biochem. Biophys. 325 (1996) 107-112
11. Caldwell S.H., and Crespo D.M. The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J. Hepatol. 40 (2004) 578-584
12. Caldwell S.H., Swerdlow R.H., Khan E.M., Iezzoni J.C., Hespenheide E.E., Parks J.K., and Parker Jr. W.D. Mitochondrial abnormalities in non-alcoholic steatohepatitis. J. Hepatol. 31 (1999) 430-434
13. Chance B., Sies H., and Boveris A. Hydroperoxide metabolism in mammalian organs. Phys. Rev. 59 (1979) 527-605
14. Chavin K.D., Yang S., Lin H.Z., Chatham J., Chacko V.P., Hoek J.B., Walajtys-Rode E., Rashid A., Chen C.H., Huang C.C., Wu T.C., Lane M.D., and Diehl A.M. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J. Biol. Chem. 274 (1999) 5692-5700
15. Colca J.R., McDonald W.G., Waldon D.J., Leone J.W., Lull J.M., Bannow C.A., Lund E.T., and Mathews W.R. Identification of a novel mitochondrial protein (mitoNEET) cross-linked specifically by a thiazolidinedione photoprobe. Am. J. Phys. Endocrinol. Metab. 286 (2004) E252-E260
16. Cortez-Pinto H., Chatham J., Chacko V.P., Arnold C., Rashid A., and Diehl A.M. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 282 (1999) 1659-1664
17. Cortez-Pinto H., de Moura M.C., and Day C.P. Non-alcoholic steatohepatitis: from cell biology to clinical practice. J. Hepatol. 44 (2006) 197-208
18. Day C.P., and James O.F. Steatohepatitis: a tale of two hits?. Gastroenterology 114 (1998) 842-845
19. Demeilliers C., Maisonneuve C., Grodet A., Mansouri A., Nguyen R., Tinel M., Letteron P., Degott C., Feldmann G., Pessayre D., and Fromenty B. Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice. Gastroenterology 123 (2002) 1278-1290
20. Donthamsetty S., Bhave V.S., Mitra M.S., Latendresse J.R., and Mehendale H.M. Nonalcoholic fatty liver sensitizes rats to carbon tetrachloride hepatotoxicity. Hepatology 45 (2007) 391-403
21. Dufour J.F. NASH and thiazolidinediones: not to be taken lightly. J. Hepatol. (2007)
22. Eaton S. Control of mitochondrial beta-oxidation flux. Prog. Lipid Res. 41 (2002) 197-239
23. Echtay K.S., Esteves T.C., Pakay J.L., Jekabsons M.B., Lambert A.J., Portero-Otin M., Pamplona R., Vidal-Puig A.J., Wang S., Roebuck S.J., and Brand M.D. A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J. 22 (2003) 4103-4110
24. Faggioni R., Shigenaga J., Moser A., Feingold K.R., and Grunfeld C. Induction of UCP2 gene expression by LPS: a potential mechanism for increased thermogenesis during infection. Biochem. Biophys. Res. Commun. 244 (1998) 75-78
25. Fromenty B., and Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol. Ther. 67 (1995) 101-154
26. Fulop P., Derdak Z., Sheets A., Sabo E., Berthiaume E.P., Resnick M.B., Wands J.R., Paragh G., and Baffy G. Lack of UCP2 reduces Fas-mediated liver injury in ob/ob mice and reveals importance of cell-specific UCP2 expression. Hepatology 44 (2006) 592-601
27. Garcia-Ruiz I., Rodriguez-Juan C., Diaz-Sanjuan T., Del Hoyo P., Colina F., Munoz-Yague T., and Solis-Herruzo J.A. Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice. Hepatology 44 (2006) 581-591
28. Garcia-Ruiz I., Rodriguez-Juan C., Diaz-Sanjuan T., Martinez M.A., Munoz-Yague T., and Solis-Herruzo J.A. Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice. Hepatology 46 (2007) 414-423
29. Guigas B., Detaille D., Chauvin C., Batandier C., De Oliveira F., Fontaine E., and Leverve X. Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study. Biochem. J. 382 (2004) 877-884
30. Gulick T., Cresci S., Caira T., Moore D.D., and Kelly D.P. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc. Natl. Acad. Sci. USA 91 (1994) 11012-11016
31. Haque M., and Sanyal A.J. The metabolic abnormalities associated with non-alcoholic fatty liver disease. Best Pract. Res. Clin. Gastroenterol. 16 (2002) 709-731
32. Hatano E., Tanaka A., Iwata S., Satoh S., Kitai T., Tsunekawa S., Inomoto T., Shinohara H., Chance B., and Yamaoka Y. Induction of endotoxin tolerance in transgenic mouse liver expressing creatine kinase. Hepatology 24 (1996) 663-669
33. Hensley K., Kotake Y., Sang H., Pye Q.N., Wallis G.L., Kolker L.M., Tabatabaie T., Stewart C.A., Konishi Y., Nakae D., and Floyd R.A. Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria. Carcinogenesis 21 (2000) 983-989
34. Herzig S., Long F., Jhala U.S., Hedrick S., Quinn R., Bauer A., Rudolph D., Schutz G., Yoon C., Puigserver P., Spiegelman B., and Montminy M. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413 (2001) 179-183
35. Heytler P.G. Uncouplers of oxidative phosphorylation. Pharmacol. Ther. 10 (1980) 461-472
36. Hui J.M., Kench J.G., Chitturi S., Sud A., Farrell G.C., Byth K., Hall P., Khan M., and George J. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 38 (2003) 420-427
37. Ip E., Farrell G.C., Robertson G., Hall P., Kirsch R., and Leclercq I. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 38 (2003) 123-132
38. Ip E., Farrell G., Hall P., Robertson G., and Leclercq I. Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice. Hepatology 39 (2004) 1286-1296
39. Kadenbach B. Intrinsic and extrinsic uncoupling of oxidative phosphorylation. Biochim. Biophys. Acta 1604 (2003) 77-94
40. Kadenbach B., Munscher C., Frank V., Muller-Hocker J., and Napiwotzki J. Human aging is associated with stochastic somatic mutations of mitochondrial DNA. Mutat. Res. 338 (1995) 161-172
41. Kelly L.J., Vicario P.P., Thompson G.M., Candelore M.R., Doebber T.W., Ventre J., Wu M.S., Meurer R., Forrest M.J., Conner M.W., Cascieri M.A., and Moller D.E. Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression. Endocrinology 139 (1998) 4920-4927
42. Kirpichnikov D., McFarlane S.I., and Sowers J.R. Metformin: an update. Ann. Intern. Med. 137 (2002) 25-33
43. Kohnke D., Ludwig B., and Kadenbach B. A threshold membrane potential accounts for controversial effects of fatty acids on mitochondrial oxidative phosphorylation. FEBS Lett. 336 (1993) 90-94
44. Korshunov S.S., Skulachev V.P., and Starkov A.A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 416 (1997) 15-18
45. Laurent A., Nicco C., Tran V.N., Borderie D., Chereau C., Conti F., Jaffray P., Soubrane O., Calmus Y., Weill B., and Batteux F. Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis. Hepatology 39 (2004) 1277-1285
46. Lee F.Y., Li Y., Zhu H., Yang S., Lin H.Z., Trush M., and Diehl A.M. Tumor necrosis factor increases mitochondrial oxidant production and induces expression of uncoupling protein-2 in the regenerating mice [correction of rat] liver. Hepatology 29 (1999) 677-687
47. Lee Y., Wang M.Y., Kakuma T., Wang Z.W., Babcock E., McCorkle K., Higa M., Zhou Y.T., and Unger R.H. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J. Biol. Chem. 276 (2001) 5629-5635
48. Lenaz G. The mitochondrial production of reactive oxygen species: mechanism and implications in human pathology. IUBMB Life 52 (2001) 159-164
49. Lickteig A.J., Fisher C.D., Augustine L.M., and Cherrington N.J. Genes of the antioxidant response undergo upregulation in a rodent model of nonalcoholic steatohepatitis. J. Biochem. Mol. Toxicol. 21 (2007) 216-220
50. Linnane A.W., Marzuki S., Ozawa T., and Tanaka M. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1 (1989) 642-645
51. Loguercio C., Federico A., Trappoliere M., Tuccillo C., Sio I., Leva A.D., Niosi M., D'Auria M.V., Capasso R., and Blanco C.V. The effect of a silybin-vitamin E-phospholipid complex on nonalcoholic fatty liver disease: a pilot study. Digest Dis. Sci. 52 (2007) 2387-2395
52. Loschen G., Azzi A., Richter C., and Flohe L. Superoxide radicals as precursors of mitochondrial hydrogen peroxide. FEBS Lett. 42 (1974) 68-72
53. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Zoli M., and Melchionda N. Metformin in non-alcoholic steatohepatitis. Lancet 358 (2001) 893-894
54. Mascaro C., Acosta E., Ortiz J.A., Marrero P.F., Hegardt F.G., and Haro D. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J. Biol. Chem. 273 (1998) 8560-8563
55. Miele L., Grieco A., Armuzzi A., Candelli M., Forgione A., Gasbarrini A., and Gasbarrini G. Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. Am. J. Gastroenterol. 98 (2003) 2335-2336
56. Miwa S., St Pierre J., Partridge L., and Brand M.D. Superoxide and hydrogen peroxide production by Drosophila mitochondria. Free Radical Biol. Med. 35 (2003) 938-948
57. Nagai Y., Nishio Y., Nakamura T., Maegawa H., Kikkawa R., and Kashiwagi A. Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha. Am. J. Phys. Endocrinol. Metab. 282 (2002) E1180-E1190
58. Nakamuta M., Kohjima M., Morizono S., Kotoh K., Yoshimoto T., Miyagi I., and Enjoji M. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int. J. Mol. Med. 16 (2005) 631-635
59. Navarro A., and Boveris A. The mitochondrial energy transduction system and the aging process. Am. J. Physiol-Cell Physiol 292 (2007) C670-C686
60. Negre-Salvayre A., Hirtz C., Carrera G., Cazenave R., Troly M., Salvayre R., Penicaud L., and Casteilla L. A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J. 11 (1997) 809-815
61. Nicholls G.C., and Ferguson S.J. Bioenergetics: An Introduction to the Chemiosmotic Theory (1992), Academy Press, New York
62. Nisoli E., Clementi E., Moncada S., and Carruba M.O. Mitochondrial biogenesis as a cellular signaling framework. Biochem. Pharmacol. 67 (2004) 1-15
63. Nocito A., Dahm F., Jochum W., Jang J.H., Georgiev P., Bader M., Renner E.L., and Clavien P.A. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis. Gastroenterology 133 (2007) 608-618
64. Okuda M., Lee H.C., Kumar C., and Chance B. Comparison of the effect of a mitochondrial uncoupler, 2,4-dinitrophenol and adrenaline on oxygen radical production in the isolated perfused rat liver. Acta Physiol Scand. 145 (1992) 159-168
65. Oliveira C.P., Costa Gayotto L.C., Tatai C., Della Bina B.I., Janiszewski M., Lima E.S., Abdalla D.S., Lopasso F.P., Laurindo F.R., and Laudanna A.A. Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet. J. Cell Mol. Med. 6 (2002) 399-406
66. Pan M., Song Y.L., Xu J.M., and Gan H.Z. Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats. J. Pineal Res. 41 (2006) 79-84
67. Paterson J.M., Morton N.M., Fievet C., Kenyon C.J., Holmes M.C., Staels B., Seckl J.R., and Mullins J.J. Metabolic syndrome without obesity: hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc. Natl. Acad. Sci. USA 101 (2004) 7088-7093
68. Perez-Carreras M., Del Hoyo P., Martin M.A., Rubio J.C., Martin A., Castellano G., Colina F., Arenas J., and Solis-Herruzo J.A. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38 (2003) 999-1007
69. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol. Aspects Med. 21 (2000) 49-98
70. Poli G., and Schaur R.J. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB. Life 50 (2000) 315-321
71. Porter R.K., and Brand M.D. Body mass dependence of H+ leak in mitochondria and its relevance to metabolic rate. Nature 362 (1993) 628-630
72. Promrat K., Lutchman G., Uwaifo G.I., Freedman R.J., Soza A., Heller T., Doo E., Ghany M., Premkumar A., Park Y., Liang T.J., Yanovski J.A., Kleiner D.E., and Hoofnagle J.H. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 39 (2004) 188-196
73. Puigserver P., and Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24 (2003) 78-90
74. Rao M.S., and Reddy J.K. Peroxisomal beta-oxidation and steatohepatitis. Semin. Liver Dis. 21 (2001) 43-55
75. Rashid A., Wu T.C., Huang C.C., Chen C.H., Lin H.Z., Yang S.Q., Lee F.Y., and Diehl A.M. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 29 (1999) 1131-1138
76. Samuhasaneeto S., Thong-Ngam D., Kulaputana O., Patumraj S., and Klaikeaw N. Effects of N-acetylcysteine on oxidative stress in rats with non-alcoholic steatohepatitis. J. Med. Assoc. Thai. 90 (2007) 788-797
77. Sanyal A.J., Campbell-Sargent C., Mirshahi F., Rizzo W.B., Contos M.J., Sterling R.K., Luketic V.A., Shiffman M.L., and Clore J.N. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120 (2001) 1183-1192
78. Schattenberg J.M., Singh R., Wang Y., Lefkowitch J.H., Rigoli R.M., Scherer P.E., and Czaja M.J. JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology 43 (2006) 163-172
79. Schulz H. Beta oxidation of fatty acids. Biochim. Biophys. Acta 1081 (1991) 109-120
80. Serviddio G., Pereda J., Pallardo F.V., Carretero J., Borras C., Cutrin J., Vendemiale G., Poli G., Vina J., and Sastre J. Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress. Hepatology 39 (2004) 711-720
81. Serviddio G., Siculella L., Giudetti A.M., Bellanti F., Romano A.D., Prigigallo F., Altomare E., and Vendemiale G. CPT-1 is a key target of mitochondria nitrosylation during NASH development. J. Hepatol. 44 (2006) S263
82. Serviddio G., Bellanti F., Romano A.D., Tamborra R., Rollo T., Altomare E., and Vendemiale G. Bioenergetics in aging: mitochondrial proton leak in aging rat liver, kidney and heart. Redox. Rep. 12 (2007) 91-95
83. Serviddio G., Bellanti F., Tamborra R., Romano A., Rollo T., Capitanio N., Vendemiale G., and Altomare E. UCP2 induces mitochondrial uncoupling during nonalcoholic steatohepatitis: an adaptive mechanism to reduce oxidative stress but producing depletion of ATP. J. Hepatol. 46 (2007) S284
84. Serviddio, G., Bellanti, F., Tamborra, R., Rollo, T., Romano, A.D., Giudetti, A.M., Capitanio, N., Petrella, A., Vendemiale, G., Altomare, E., 2008. Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model. Eur. J. Clin. Invest., in press.
85. Shulman A.I., and Mangelsdorf D.J. Retinoid x receptor heterodimers in the metabolic syndrome. New Engl. J. Med. 353 (2005) 604-615
86. Silverman J.F., O'Brien K.F., Long S., Leggett N., Khazanie P.G., Pories W.J., Norris H.T., and Caro J.F. Liver pathology in morbidly obese patients with and without diabetes. Am. J. Gastroenterol. 85 (1990) 1349-1355
87. Skulachev V.P. Uncoupling: new approaches to an old problem of bioenergetics. Biochim. Biophys. Acta 1363 (1998) 100-124
88. Sonoda J., Mehl I.R., Chong L.W., Nofsinger R.R., and Evans R.M. PGC-1beta controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis. Proc. Natl. Acad. Sci. USA 104 (2007) 5223-5228
89. Spiegelman B.M. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 47 (1998) 507-514
90. Sreekumar R., Rosado B., Rasmussen D., and Charlton M. Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis. Hepatology 38 (2003) 244-251
91. St Pierre J., Buckingham J.A., Roebuck S.J., and Brand M.D. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem. 277 (2002) 44784-44790
92. Starkel P., Sempoux C., Leclercq I., Herin M., Deby C., Desager J.P., and Horsmans Y. Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J. Hepatol. 39 (2003) 538-546
93. Svegliati-Baroni G., Candelaresi C., Saccomanno S., Ferretti G., Bachetti T., Marzioni M., De Minicis S., Nobili L., Salzano R., Omenetti A., Pacetti D., Sigmund S., Benedetti A., and Casini A. A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. Am. J. Pathol. 169 (2006) 846-860
94. Tapner M.J., Jones B.E., Wu W.M., and Farrell G.C. Toxicity of low dose azathioprine and 6-mercaptopurine in rat hepatocytes. Roles of xanthine oxidase and mitochondrial injury. J. Hepatol. 40 (2004) 454-463
95. Terada H. Uncouplers of oxidative phosphorylation. Environ. Health Persp. 87 (1990) 213-218
96. Tontonoz P., Hu E., and Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79 (1994) 1147-1156
97. Uto H., Nakanishi C., Ido A., Hasuike S., Kusumoto K., Abe H., Numata M., Nagata K., Hayashi K., and Tsubouchi H. The peroxisome proliferator-activated receptor-gamma agonist, pioglitazone, inhibits fat accumulation and fibrosis in the livers of rats fed a choline-deficient, l-amino acid-defined diet. Hepatol. Res. 32 (2005) 235-242
98. Velasco G., Gomez d.P., Carling D., and Guzman M. Evidence that the AMP-activated protein kinase stimulates rat liver carnitine palmitoyltransferase I by phosphorylating cytoskeletal components. FEBS Lett. 439 (1998) 317-320
99. Vendemiale G., Grattagliano I., Caraceni P., Caraccio G., Domenicali M., Dall'Agata M., Trevisani F., Guerrieri F., Bernardi M., and Altomare E. Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: effect of the nutritional status. Hepatology 33 (2001) 808-815
100. Videla L.A., Rodrigo R., Orellana M., Fernandez V., Tapia G., Quinones L., Varela N., Contreras J., Lazarte R., Csendes A., Rojas J., Maluenda F., Burdiles P., Diaz J.C., Smok G., Thielemann L., and Poniachik J. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin. Sci. (Lond) 106 (2004) 261-268
101. Villarroya F., Iglesias R., and Giralt M. PPARs in the Control of Uncoupling Proteins Gene Expression. PPAR Res. 2007 (2006) 74364
102. Wallace D.C. Diseases of the mitochondrial DNA. Annu. Rev. Biochem. 61 (1992) 1175-1212
103. Wallace D.C. Mitochondrial genetics: a paradigm for aging and degenerative diseases?. Science 256 (1992) 628-632
104. Wanless I.R., and Lentz J.S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12 (1990) 1106-1110
105. Winder W.W., and Hardie D.G. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am. J. Physiol. 277 (1999) E1-E10
106. Winder W.W., Holmes B.F., Rubink D.S., Jensen E.B., Chen M., and Holloszy J.O. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J. Appl. Physiol. 88 (2000) 2219-2226
107. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., Troy A., Cinti S., Lowell B., Scarpulla R.C., and Spiegelman B.M. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98 (1999) 115-124
108. Yang S., Zhu H., Li Y., Lin H., Gabrielson K., Trush M.A., and Diehl A.M. Mitochondrial adaptations to obesity-related oxidant stress. Arch. Biochem. Biophys. 378 (2000) 259-268
109. Yin M., Gabele E., Wheeler M.D., Connor H., Bradford B.U., Dikalova A., Rusyn I., Mason R., and Thurman R.G. Alcohol-induced free radicals in mice: direct toxicants or signaling molecules?. Hepatology 34 (2001) 935-942
110. Yki-Jarvinen H. Thiazolidinediones. New Engl. J. Med. 351 (2004) 1106-1118
111. Yu G.S., Lu Y.C., and Gulick T. Co-regulation of tissue-specific alternative human carnitine palmitoyltransferase Ibeta gene promoters by fatty acid enzyme substrate. J. Biol. Chem. 273 (1998) 32901-32909
112. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M.F., Goodyear L.J., and Moller D.E. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108 (2001) 1167-1174